{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:36:02Z","timestamp":1775522162080,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,21]],"date-time":"2015-02-21T00:00:00Z","timestamp":1424476800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-0824-0","type":"journal-article","created":{"date-parts":[[2015,2,20]],"date-time":"2015-02-20T07:17:50Z","timestamp":1424416670000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Effectiveness of topical corticosteroids in addition to antiviral therapy in the management of recurrent herpes labialis: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"15","author":[{"given":"Nasira","family":"Arain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharath CV","family":"Paravastu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mubashir A","family":"Arain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,21]]},"reference":[{"issue":"5","key":"824_CR1","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jaad.2007.06.027","volume":"57","author":"M Fatahzadeh","year":"2007","unstructured":"Fatahzadeh M, Schwartz R. Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. J Am Acad Dermatol. 2007;57(5):737\u201363. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17939933 [Accessed: 15th June 2014].","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"824_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1600-0714.2011.01037.x","volume":"41","author":"S Skulason","year":"2012","unstructured":"Skulason S, Peter Holbrook W, Thormar H, Gunnarsson G, Kristmundsdottir T. A study of the clinical activity of a gel combining monocaprin and doxycycline: a novel treatment for herpes labialis. J Oral Pathol Med. 2012;41(1):61\u20137.","journal-title":"J Oral Pathol Med"},{"key":"824_CR3","unstructured":"Worrall, G. Herpes labialis. BMJ Clin Evid. 2009 Sep 23;2009. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21726482 [Accessed: 19th June 2014]."},{"issue":"8","key":"824_CR4","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1001\/jama.296.8.964","volume":"296","author":"F Xu","year":"2006","unstructured":"Xu F, Sternberg M, Kottiri B, Mcquillan G, Lee F, Nahmias A, et al. Trends in Herpes Simplex Virus Type 1 and Type 2 Seroprevalence in the United States. JAMA. 2006;296(8):964\u201373. Available at: http:\/\/jama.jamanetwork.com\/article.aspx?articleid=203222 [Accessed: 5th July 2014].","journal-title":"JAMA"},{"key":"824_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/bmb\/ldt011","volume":"106","author":"H Field","year":"2013","unstructured":"Field H, Vere Hodge R. Recent developments in anti-herpesvirus drugs. Br Med Bull. 2013;106:213\u201349.","journal-title":"Br Med Bull"},{"issue":"7350","key":"824_CR6","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1136\/bmj.324.7350.1366","volume":"324","author":"A Scoular","year":"2002","unstructured":"Scoular A, Norrie J, Gillespie G, Mir N, Carman W. Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15 years. Br Med J. 2002;324(7350):1366\u201313667. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC115212\/ [Accessed: 20th June 2014].","journal-title":"Br Med J"},{"issue":"2","key":"824_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2340\/00015555-0806","volume":"90","author":"J Harmenberg","year":"2010","unstructured":"Harmenberg J, Oberg B, Spruance S. Prevention of ulcerative lesions by episodic treatment of recurrent herpes labialis: A literature review. Acta Derm Venereol. 2010;90(2):122\u201330. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20169294 [Accessed: 5th Aug 2013].","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"824_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1600-0714.2007.00586.x","volume":"37","author":"P Arduino","year":"2008","unstructured":"Arduino P, Porter S. Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features. J Oral Pathol Med. 2008;37(2):107\u201321. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18197856 [Accessed: 2nd Feb 2013].","journal-title":"J Oral Pathol Med"},{"key":"824_CR9","first-page":"2050","volume":"14","author":"G Worrall","year":"2005","unstructured":"Worrall G. Herpes labialis. Clin Evid. 2005;14:2050\u20137.","journal-title":"Clin Evid"},{"issue":"12","key":"824_CR10","first-page":"1683","volume":"54","author":"W Opstelten","year":"2008","unstructured":"Opstelten W, Neven A, Eekhof J. Treatment and prevention of herpes labialis. Can Fam Physician. 2008;54(12):1683\u20137. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2602638\/ [Accessed: 9th Apr 2013].","journal-title":"Can Fam Physician"},{"issue":"8","key":"824_CR11","first-page":"498","volume":"69","author":"G Raborn","year":"2003","unstructured":"Raborn G, Grace M. Recurrent herpes simplex labialis: selected therapeutic options. J Can Dental Assoc. 2003;69(8):498\u2013503. Available at: https:\/\/www.ncbi.nlm.nih.gov\/m\/pubmed\/12954137\/?i=4&from=\/15293697\/related [Accessed: 17th June 2013].","journal-title":"J Can Dental Assoc"},{"issue":"5","key":"824_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3810\/pgm.2010.09.2216","volume":"122","author":"C Hull","year":"2011","unstructured":"Hull C, Brunton S. The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese\u2122) in the treatment of recurrent herpessimplex labialis. Postgrad Med. 2011;122(5):1\u20136. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20873400 [Accessed: 4th Feb 2013].","journal-title":"Postgrad Med"},{"issue":"1","key":"824_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1525-1470.2011.01570.x","volume":"29","author":"A Strand","year":"2012","unstructured":"Strand A, B\u00f6ttiger D, Gever L, Wheeler W. Safety and tolerability of combination acyclovir 5% and hydrocortisone 1% cream in adolescents with recurrent herpes simplex labialis. Pediatr Dermatol. 2012;29(1):105\u201310. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22004219 [Accessed: 9th Feb 2013].","journal-title":"Pediatr Dermatol"},{"key":"824_CR14","unstructured":"Aciclovir + hydrocortisone. Herpes labialis: a topical antiviral drug perhaps, but not a steroid. Prescrire Int.\u20092011 Sep;20(119):205-7. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21954513 [Accessed: 15th Feb 2015]."},{"issue":"6","key":"824_CR15","first-page":"348","volume":"8","author":"N Scheinfeld","year":"2010","unstructured":"Scheinfeld N. New to the clinic: Therapeutic Review 2009\u20132010. SKINmed. 2010;8(6):348\u20139. Available at: http:\/\/skinmedjournal.com\/skinmed_v8i6_l.pdf#page=42 [Accessed: 5th Sep 2013].","journal-title":"SKINmed"},{"key":"824_CR16","doi-asserted-by":"crossref","unstructured":"Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.\u2009BMJ\u00a02011;343:d5928. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3196245 [Accessed: 15th Feb 2015].","DOI":"10.1136\/bmj.d5928"},{"key":"824_CR17","doi-asserted-by":"crossref","unstructured":"Hozo S, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology.2005;5:13. Available at: http:\/\/www.biomedcentral.com\/1471-2288\/5\/13 [Accessed: 6th Aug 2013].","DOI":"10.1186\/1471-2288-5-13"},{"key":"824_CR18","doi-asserted-by":"crossref","unstructured":"Hull C, Harmenberg J, Arlander E, Aoki F, Bring J, Darp\u00f6 B, et al. Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: a randomized, double-blind, placebo-controlled, patient-initiated clinical trial. J Am Acad Dermatol. 2010;64(4):696.e1-1. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20851499 [Accessed: 05th Mar 2013].","DOI":"10.1016\/j.jaad.2010.08.012"},{"key":"824_CR19","doi-asserted-by":"crossref","unstructured":"Evans T, Bernstein D, Raborn G, Harmenberg J, Kowalski J, Spruance S, et.al. Double-blind, randomized, placebocontrolled study of topical 5% acyclovir,1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis. Antimicrobial agents and chemotherapy. 2002;46(6):1870\u20134. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12019102 [Accessed: 20th Mar 2013].","DOI":"10.1128\/AAC.46.6.1870-1874.2002"},{"key":"824_CR20","doi-asserted-by":"crossref","unstructured":"Hull C, Mckeough M, Sebastian K, Kriesel J, Spruance S. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial. J Eur Acad Dermatol Venereol. 2009;23(3):263\u20137. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19143902 [Accessed: 18th May 2013].","DOI":"10.1111\/j.1468-3083.2008.03047.x"},{"key":"824_CR21","doi-asserted-by":"crossref","unstructured":"Spruance S, Mckeough M. Combination treatment with famciclovir and a topical corticosteroid gel versus famciclovir alone for experimental ultraviolet radiation-induced herpes simplex labialis: a pilot study. J Infect Dis. 2000;181(6):1906\u201310. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10837169 [Accessed: 2nd May 2013].","DOI":"10.1086\/315528"},{"key":"824_CR22","doi-asserted-by":"crossref","unstructured":"Spruance S, Nett R, Marbury T, Wolff R, Johnson J, Spaulding T, et.al. Acyclovir cream for the treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials. Antimicrob Agents Chemother. 2002;46(7):2238\u201343. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12069980 [Accessed: 6th Aug 2013].","DOI":"10.1128\/AAC.46.7.2238-2243.2002"},{"key":"824_CR23","doi-asserted-by":"crossref","unstructured":"Raborn G, Martel A, Lassonde M, Lewis M, Boon R, Spruance S, et.al. Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials. J Am Dental Assoc. 2002;133(3):303\u20139. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11934185 [Accessed: 7th Aug 2013].","DOI":"10.14219\/jada.archive.2002.0169"},{"key":"824_CR24","doi-asserted-by":"crossref","unstructured":"Kaminester L, Pariser R, Pariser D, Weiss J, Shavin J, Landsman L, et al. A double-blind, placebo-controlled study of topical tetracaine in the treatment of herpes labialis. J Am Acad Dermatol. 1999; 41(6):996\u20131001. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10570387 [Accessed: 15th Apr 2013].","DOI":"10.1016\/S0190-9622(99)70260-4"},{"key":"824_CR25","unstructured":"Sperandio F, Marotti J, Aranha A, Eduardo Cde P. Photodynamic therapy for the treatment of recurrent herpes labialis: preliminary results. Gen Dent. 2009;57(4):415\u20139. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19903625 [Accessed: 6th Aug 2013]."},{"key":"824_CR26","doi-asserted-by":"crossref","unstructured":"Harmenberg J, Awan A, Alenius S, St\u00e5hle L, Erlandsson A, Lekare G, et al. Augustsson E, Larsson T, Wikstr\u00f6m A, Stierna P, Field H, Larsson A. ME-609: a treatment for recurrent herpes simplex virus infections. Antivir Chem Chemother. 2003;14(4):205\u201315. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14582849 [Accessed: 4th Aug 2013].","DOI":"10.1177\/095632020301400405"},{"key":"824_CR27","doi-asserted-by":"crossref","unstructured":"Woo S, Challacombe S. Management of recurrent oral herpes simplex infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103(S12):e1-18. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17379150 [Accessed: 4th Aug 2013].","DOI":"10.1016\/j.tripleo.2006.11.004"},{"key":"824_CR28","volume-title":"Paper presented at Thirty-sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, La","author":"G Raborn","year":"1996","unstructured":"Raborn G, for the Penciclovir Topical Collaborative Study Group. Paper presented at Thirty-sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, La. 1996."},{"key":"824_CR29","doi-asserted-by":"crossref","unstructured":"Spruance S, Rea T, Thoming C, Tucker R, Saltzman R, Boon R, et.al. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group. J Am Med Assoc. 1997;277(17):1374\u20139. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9134943 [Accessed: 2nd Aug 2013].","DOI":"10.1001\/jama.1997.03540410052030"},{"issue":"1","key":"824_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jaad.2006.02.031","volume":"55","author":"S Spruance","year":"2006","unstructured":"Spruance S, Bodsworth N, Resnick H, Conant M, Oeuvray C, Gao J, et al. Single-dose, patient-initiated famciclovir: a randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis. J Am Acad Dermatol. 2006;55(1):47\u201353. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16781291 [Accessed: 19 Mar 2013].","journal-title":"J Am Acad Dermatol"},{"key":"824_CR31","doi-asserted-by":"crossref","unstructured":"Spruance S, Jones T, Blatter M, Vargas-Cortes M, Barber J, et al. High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies. Antimicrob Agents Chemother. 2003;47(3):1072\u201380. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12604544 [Accessed: 12th Mar 2013].","DOI":"10.1128\/AAC.47.3.1072-1080.2003"},{"issue":"4","key":"824_CR32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/19424396.2013.12222300","volume":"41","author":"ET Stoopler","year":"2013","unstructured":"Stoopler ET, Balasubramaniam R. Topical and systemic therapies for oral and perioral herpes simplex virus infections. J Calif Dent Assoc. 2013;41(4):259\u201362.","journal-title":"J Calif Dent Assoc"},{"key":"824_CR33","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1056\/NEJM199904223401608","volume":"340","author":"HH Balfour Jr","year":"1999","unstructured":"Balfour Jr HH. Antiviral drugs. N Engl J Med. 1999;340:1255\u201368.","journal-title":"N Engl J Med"},{"issue":"8780","key":"824_CR34","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/0140-6736(91)92723-F","volume":"338","author":"JF Rooney","year":"1991","unstructured":"Rooney JF, Bryson Y, Mannix ML, Dillon M, Wohlenberg CR, Banks S, et al. Prevention of ultraviolet-light-induced herpes labialis by sunscreen. Lancet. 1991;338(8780):1419\u201322.","journal-title":"Lancet"},{"issue":"3","key":"824_CR35","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1128\/JCM.22.3.366-368.1985","volume":"22","author":"SL Spruance","year":"1985","unstructured":"Spruance SL. Pathogenesis of herpes simplex labialis: experimental induction of lesions with UV light. J Clin Microbiol. 1985;22(3):366\u20138.","journal-title":"J Clin Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-015-0824-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0824-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0824-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0824-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T15:53:40Z","timestamp":1691337220000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-0824-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,21]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["824"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-0824-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,21]]},"assertion":[{"value":"1 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"82"}}